B. Jasińska‐Myga

发表

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

J. Schiefer, R. Barker, R. Reilmann, 2011, PLoS currents.

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease

Matthew J. Farrer, Owen A. Ross, Alexandra I. Soto-Ortolaza, 2010, neurogenetics.

Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research

Martin N. Rossor, Margaret Sutherland, Colin J. Mahoney, 2012, PloS one.

Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

K. Heilman, M. Barcikowska, A. Barczak, 2014, Neurocase.

Calbindin‐1 association and Parkinson’s disease

M. Farrer, M. Barcikowska, R. Uitti, 2010, European journal of neurology.

SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study

M. Farrer, R. Uitti, M. Heckman, 2011, European journal of neurology.

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.

Christian Wider, Kenya Nishioka, Dennis W Dickson, 2010, Archives of neurology.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

A. Destée, D. Serie, M. Farrer, 2014, Neurobiology of Aging.

Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium

D. Maraganore, D. Dickson, C. van Broeckhoven, 2013, Movement disorders : official journal of the Movement Disorder Society.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

J. Ioannidis, M. Farrer, D. Maraganore, 2012, Journal of Medical Genetics.

Large-scale replication and heterogeneity in Parkinson disease genetic loci

J. Ioannidis, M. Farrer, D. Maraganore, 2012, Neurology.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

J. Ioannidis, M. Farrer, D. Maraganore, 2011, The Lancet Neurology.

Human leukocyte antigen variation and Parkinson's disease.

M. Barcikowska, R. Uitti, M. Heckman, 2011, Parkinsonism & related disorders.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

A. Destée, J. Ioannidis, M. Farrer, 2011, Annals of neurology.

Death‐associated protein kinase 1 variation and Parkinson’s disease

M. Farrer, M. Barcikowska, R. Uitti, 2011, European journal of neurology.

Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.

Anna Potulska-Chromik, Piotr Janik, Dariusz Koziorowski, 2013, Parkinsonism & related disorders.

Heterodimerization of Lrrk1–Lrrk2: Implications for LRRK2-associated Parkinson disease

M. Farrer, J. Kachergus, S. Lincoln, 2010, Mechanisms of Ageing and Development.

Frontotemporal dementia and parkinsonism linked to chromosome 17 – the first Polish family

Z. Wszolek, M. Baker, P. Lass, 2011, European journal of neurology.

Genetics of essential tremor.

C. Wider, B. Jasińska-Myga, B. Jasińska‐Myga, 2012, Parkinsonism & related disorders.

Early-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional study.

Elisabeth L. Moussaud-Lamodière, J. Siuda, G. Opala, 2014, Parkinsonism & related disorders.

PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

M. Farrer, M. Barcikowska, G. Opala, 2012, Parkinsonism & related disorders.

Depression in Parkinson's Disease

R. Uitti, J. Putzke, Z. Wszolek, 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.

C. Goetz, S. Ochudło, G. Opala, 2007, Archives of neurology.

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease

J. Ioannidis, M. Farrer, D. Maraganore, 2011, Neurobiology of Aging.

LINGO1 rs9652490 is associated with essential tremor and Parkinson disease.

M. Farrer, J. Kachergus, R. Uitti, 2010, Parkinsonism & related disorders.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

Aldo Quattrone, Nobutaka Hattori, Anthony E. Lang, 2011, Neurobiology of Aging.

Loss of ability to work and ability to live independently in Parkinson's disease.

R. Uitti, M. Heckman, J. Putzke, 2012, Parkinsonism & related disorders.